Left to right: Clare Gibbons – Research Manager, Dr. Phillippe Rizek – Neurologist and PI, Rebecca Searles – Research Coordinator
Left to right: Clare Gibbons – Research Manager, Dr. Phillippe Rizek – Neurologist and PI, Rebecca Searles – Research Coordinator
#Huntingtonsdisease
In mid-October 2025, the next HDClinical Research Congress will take place, in Nashville USA.
The Congress will be being hosted jointly by CHDI and the Huntington Study Group (HSG).
#Huntingtonsdisease
In mid-October 2025, the next HDClinical Research Congress will take place, in Nashville USA.
The Congress will be being hosted jointly by CHDI and the Huntington Study Group (HSG).
There are currently many exciting clinical trials underway with an aim of preventing or slowing down the progression of Huntington's disease #Huntingtonsdisease #HDClarity
There are currently many exciting clinical trials underway with an aim of preventing or slowing down the progression of Huntington's disease #Huntingtonsdisease #HDClarity
Samples from the HDClarity study are widely used in publications and presentations surrounding Huntington’s disease.
Samples from the HDClarity study are widely used in publications and presentations surrounding Huntington’s disease.
To take part, individuals must first already be enrolled in, or be recruited into, the Enroll-HD study. This study collects natural history data in HD individuals and controls, and this data is linked with the biosamples collected during HDClarity participation.
To take part, individuals must first already be enrolled in, or be recruited into, the Enroll-HD study. This study collects natural history data in HD individuals and controls, and this data is linked with the biosamples collected during HDClarity participation.
We have some exciting updates on the progression of the HDClarity study #HuntingtonsDisease #HDClarityStudy
We have some exciting updates on the progression of the HDClarity study #HuntingtonsDisease #HDClarityStudy
HDClarity is a longitudinal open-ended observational study. The main objective of the study is to collect high-quality cerebrospinal fluid samples for longitudinal evaluation of biomarkers and pathways which will enable the development of novel treatments for #HuntingtonsDisease
HDClarity is a longitudinal open-ended observational study. The main objective of the study is to collect high-quality cerebrospinal fluid samples for longitudinal evaluation of biomarkers and pathways which will enable the development of novel treatments for #HuntingtonsDisease
HDClarity is a longitudinal open-ended observational study. The main objective of the study is to collect high-quality cerebrospinal fluid samples for longitudinal evaluation of biomarkers and pathways which will enable the development of novel treatments for #HuntingtonsDisease
HDClarity is a longitudinal open-ended observational study. The main objective of the study is to collect high-quality cerebrospinal fluid samples for longitudinal evaluation of biomarkers and pathways which will enable the development of novel treatments for #HuntingtonsDisease